IL17A and rheumatoid arthritis: (176) performed an experimental study and found that Lactobacillus casei can inhibit the development of RA in rats by changing the intestinal microbiome, inhibiting the levels of IL-17, IL-1β, IL-6, and TNF-α in inflammatory cells, and changing the ratio of Th1/Th17.